InvestorsHub Logo
icon url

Vegas Stocks

05/01/20 10:58 AM

#72972 RE: clambottler #72969

I agree with you. It’s not me talking about it, it’s the news. I think we have the best drug out there. I don’t know enough about the Remdesivir to say ‘it kills’ but I know that I would want Leronlimab for me or my friends & family.
I just have one question for you, does Remdesivir kill?
icon url

Badge04

05/01/20 11:07 AM

#72977 RE: clambottler #72969

LOS is such a laughable metric especially with multi center trials. Most people would be astonished at the discussions we have on the inpatient side regarding transfers, discharge summaries, etc..

If that’s a talking point, the drug being evaluated has missed the mark with actual primary outcomes that matter clinically.

Leronlimab will win this race...